Please complete the CAPTCHA to continue
@novartis.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Karine Corcelle is listed as Global R&D and Access #Innovation #Equity #Explorer at Drugs for Neglected Diseases initiative - DNDi, a company with 325 employees, based in Geneva, Geneva, Switzerland. AeroLeads shows a work email signal at novartis.com and a matched LinkedIn profile for Karine Corcelle.
Karine Corcelle previously worked as Regulatory Sciences Leader at Drugs For Neglected Diseases Initiative - Dndi and Sr Regulatory Sciences Manager at Drugs For Neglected Diseases Initiative - Dndi. Karine Corcelle holds Master'S Degree, Law And Policies Of The European Union: Health Products Law from University Of Strasbourg.
This section adds company-level context without repeating Karine Corcelle's masked contact details.
AeroLeads found 1 current-domain work email signal for Karine Corcelle. Compare company email patterns before reaching out.
Over 20 years of strong engagement with regulators, NGOs, Industry and prescribers/ patients to developstrategic innovation in regulatory science and pharmaceutical development, as well as implementstructural and cultural changes to take up the next healthcare challenges.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Geneva, Switzerland
Expand role and actions to:- Enable LMICs to meaningfully participate in joint-regulatory assessment and build respective capacity and expertise. Develop regulatory strategies and advocate for the use of facilitated registration pathways (i.e. EU M4All, Swissmedic MAGHP...).- Joining forces with WHO (GAP-f), academic partners/ research institutes, and.
Genève, Suisse
Lead/ Co-lead with partners all regulatory strategies to optimize neglected patient access to DNDi product portfolio under development in Leishmaniasis, Sleeping Sickness, HIV-Cryptococcal Meningitis.- Fexinidazole registration in rhodesiense Human African Trypanosomiasis patients through EU M4All.- Many consultations with regulators, and stakeholders on.
Bâle, Suisse
- Drive regulatory strategies for Global Health Flagship Programs (Malaria and Leprosy) with the goal of ensuring high patient reach and access to medicines.- Regulatory leadership on Novartis Adaptive Development initiative to improve access to medicine, safety and efficacy, to vulnerable patient groups (incl. children, women, elderly).- Co-develop a.
Basel Area, Switzerland
Regulatory Lead for global programs (NCEs & biologics) from early development to registration. Frequent Scientific Advice/ regulatory interactions: EMA, Swissmedic, French ANSM, Singapore SFDA,.- Registration of Myfortic® as a treatment for Lupus Nephritis in Asia and Middle-East based on Real-World Data.- Extension of Diovan® for use in hypertension in.
Basel Area, Switzerland
- Management of all submission of Early Development and Global Health Units,- Novartis representative at EFPIA eSubmission Working Group from 2010 to 2014 (previously TiGes) developing strategies, standards and best practices to drive the eCTD roadmap in EU.- Off-shoring of submission management activities in India.
Basel, Switzerland
- Lead cross-functional teams of scientist through the preparation of EU/US MAA/NDA registrations (i.e. Respiratory: Tobi® Podhaler; Oncology: Signifor®, Jakavi®...) and participated to EMA MAA pre-submission meetings.- Technical lead of various workstreams/ pilots adapting the organization to new EU regulatory framework: (1) overall modernization/.
Basel Area, Switzerland
- Development of several innovative drug delivery systems for ophthalmic diseases, skin conditions and oncology. Prepared regulatory documentation for CMC Modules submission.. Responsible for assessing in-licensing opportunities of new formulation principles/ excipients/ devices. Patents/ Inventions: WO2008074853A1 (WIPO (PTC)) Ophthalmic rebamaipide.
Évreux, Normandy, France
- Set-up a laboratory for the technical evaluation of inhalation devices and led method transfers from UK facility.- Help Altran Group to create and develop their portfolio of new pharmaceutical services.
Lyon Area, France
- Explore and characterized novel vaccine adjuvants for HIV and Hepatitis B.- Mobilize researchers' expertise and develop in-vitro methods for the early assessment of the immune-modulatory effect of vaccine adjuvants for preclinical POC.
Other employees you can reach at dndi.org. View company contacts for 325 employees →
Nicolas Scozzafave
Colleague at Drugs For Neglected Diseases Initiative - DndiChallex, Auvergne-Rhône-Alpes, France, France
View →
HA
Haneen Aljaghbeer
Colleague at Drugs For Neglected Diseases Initiative - DndiJordan, Jordan
View →
OL
Océane Laurent
Colleague at Drugs For Neglected Diseases Initiative - DndiGeneva, Geneva, Switzerland, Switzerland
View →
AF
Aondokaa Felicity
Colleague at Drugs For Neglected Diseases Initiative - DndiLagos, Lagos State, Nigeria, Nigeria
View →
MM
Masako Matsudaira
Colleague at Drugs For Neglected Diseases Initiative - DndiTokyo, Tokyo, Japan, Japan
View →
RG
Ramon Guerra De Oliveira
Colleague at Drugs For Neglected Diseases Initiative - DndiCampinas, São Paulo, Brazil, Brazil
View →
AT
Alexandre Tremblay
Colleague at Drugs For Neglected Diseases Initiative - DndiShannon, Quebec, Canada, Canada
View →
OM
Osman Murat Evrensel
Colleague at Drugs For Neglected Diseases Initiative - DndiAnkara, Ankara, Türkiye, Turkey
View →
GD
Graciela Diap
Colleague at Drugs For Neglected Diseases Initiative - DndiGreater Barcelona Metropolitan Area, Spain
View →
JP
Julia Pittorino
Colleague at Drugs For Neglected Diseases Initiative - DndiNew York City Metropolitan Area, United States
View →
Quick answers generated from the profile data available on this page.
Karine Corcelle works for Drugs for Neglected Diseases initiative - DNDi.
Karine Corcelle is listed as Global R&D and Access #Innovation #Equity #Explorer at Drugs for Neglected Diseases initiative - DNDi.
AeroLeads has found 1 work email signal at @novartis.com for Karine Corcelle at Drugs for Neglected Diseases initiative - DNDi.
Karine Corcelle is based in Geneva, Geneva, Switzerland while working with Drugs for Neglected Diseases initiative - DNDi.
Karine Corcelle has worked for Drugs For Neglected Diseases Initiative - Dndi, Novartis Global Health, Novartis, Gsk, and Sanofi Pasteur.
Karine Corcelle's colleagues at Drugs for Neglected Diseases initiative - DNDi include Nicolas Scozzafave, Haneen Aljaghbeer, Océane Laurent, Aondokaa Felicity, and Masako Matsudaira.
You can use AeroLeads to view verified contact signals for Karine Corcelle at Drugs for Neglected Diseases initiative - DNDi, including work email, phone, and LinkedIn data when available.
Karine Corcelle holds Master'S Degree, Law And Policies Of The European Union: Health Products Law from University Of Strasbourg.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Karine Corcelle you were looking for.
